33 W. Monroe Street Suite 600
Chicago, IL 60603
Tel: 312.894.5500
Fax: 312-894-5526


Featured Work

This is an awareness campaign for Teva Oncology. While it is considered the 10th largest oncology company in the US, awareness among key stakeholders was low. AbelsonTaylor sought to change that by developing a campaign emphasizing how Teva Oncology focuses on the patient. The awareness campaign was introduced at ASCO in May 2014. Qualitatively, the responses have been extremely positive.

Why This Work is Special:

Our creative team developed a campaign where emotion emanates from every image and every word. By taking common words in oncology – chemotherapy, apoptosis, metastasis, malignancy – and finding the “hidden meaning” within them, the campaign, “In a Word,” shows that cancer touches more than just the patient. The tagline, “We see so much more than just cancer,” reiterates Teva Oncology’s vision.

Creative/Account Team:

Brad Graetz, Creative Director; Tom Mateja, Assoc. Creative Director, Art; Dave Stratton, Senior Copywriter; Kevin Tran, Senior Art Director; Robert Williams, Assoc. Creative Director, Copy. Account Team: Andrea Kartley, Account Supervisor; Molly Korsch, Senior Account Supervisor; Claire Ogdon, Account Executive; Mike Perry, VP, Account Director

  • Company Resources
  • Quality Assurance Best Practices in Digital Marketing

    Featured White Paper

    Quality Assurance Best Practices in Digital Marketing is the work of like-minded people – pharma, agencies, and QA professionals – focused on reducing costly QA problems than can surface when developing digital products. AbelsonTaylor has been helping clients improve the quality outcomes of their digital products for more than 15 years. The White Paper is an example of our established approach to digital QA.

Director of Communication:
Gretchen Kren

Turning agencies' blues into children's cheer

AbelsonTaylor delivered a perfect pitch of a different kind last night when the agency's in-house ensemble, Hard to Swallow, won Pharmapalooza 6, the industry's annual battle of the bands contest.

Pharma's iPad, emerging-markets strategies to get 2nd look in 2013, agency execs predict

From tech shifts to talent, and from emerging markets to engaging with social media, agency execs offer their predictions for what the New Year will bring.

Private View: Breaking the Healthcare Barriers

Consumer work that creatively breaks the healthcare barriers and, most importantly, drives customers to act

AMM honors top journal ads

The Association of Medical Media (AMM) will honor the top journal ads in 13 categories at its annual Doctors' Choice awards luncheon, September 24, at The Palace Hotel in New York City.

Email Newsletters

What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.